Bajramagic, M.* et al. Artificial intelligence-driven clinical decision support systems to assist healthcare professionals and people with diabetes in Europe at the point of care: a Delphi-based consensus roadmap. Diabetologia, DOI: 10.1007/s00125-025-06601-5 (2025)
Bonifacio, E.* et al. The efficacy of islet autoantibody screening with or without genetic pre-screening strategies for the identification of presymptomatic type 1 diabetes. Diabetologia 68, 1101-1107 (2025)
Mori, T.* et al. Recognising, quantifying and accounting for classification uncertainty in type 2 diabetes subtypes. Diabetologia 68, 2139-2150 (2025)
Parajuli, A.* et al. Frequent longitudinal blood microsampling and proteome monitoring identify disease markers and enable timely intervention in a mouse model of type 1 diabetes. Diabetologia 68, 2277-2289 (2025)
Phillip, M.* et al. Considerations for more actionable consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes. Reply to Mallone R [letter]. Diabetologia 68, 892–895 (2025)
Richardson, S.J.* et al. Joint analysis of the nPOD-Virus Group data: The association of enterovirus with type 1 diabetes is supported by multiple markers of infection in pancreas tissue. Diabetologia 68, 1226-1241 (2025)
Rodriguez-Calvo, T. et al. Enterovirus VP1 protein and HLA class I hyperexpression in pancreatic islet cells of organ donors with type 1 diabetes. Diabetologia 68, 1197-1210 (2025)
Schreier, P.C.F.* et al. GLP-1/GIP/GCG receptor triagonist (IUB447) enhances insulin secretion via GLP-1 receptor and Gαq signalling pathway in mice. Diabetologia, DOI: 10.1007/s00125-025-06525-0 (2025)
Sinke, L.* et al. DNA methylation of genes involved in lipid metabolism drives adiponectin levels and metabolic disease. Diabetologia, DOI: 10.1007/s00125-025-06549-6 (2025)
Zapardiel-Gonzalo, J. ; Ziegler, A.-G. & Bonifacio, E.* The genetic architecture of type 1 diabetes over time: How well can we rely on past data to predict the future? Diabetologia 68, 1352–1354 (2025)
Apaolaza Gallegos, S.P. et al. Quantitative analysis of islet prohormone convertase 1/3 expression in human pancreas donors with diabetes. Diabetologia, DOI: 10.1007/s00125-024-06275-5 (2024)
Blüher, M. ; Rosenstock, J.* ; Hoefler, J.* ; Manuel, R.* & Hennige, A.M.* Correction to: Dose-response effects on HbA1c and bodyweight reduction of survodutide, a dual glucagon/GLP-1 receptor agonist, compared with placebo and open-label semaglutide in people with type 2 diabetes: A randomised clinical trial. Diabetologia 67, 758-758 (2024)
Gottmann, P.* et al. Transcriptomic heterogeneity of non-beta islet cells is associated with type 2 diabetes development in mouse models. Diabetologia, DOI: 10.1007/s00125-024-06301-6 (2024)
Hummel, S. et al. Early-childhood body mass index and its association with the COVID-19 pandemic, containment measures and islet autoimmunity in children with increased risk for type 1 diabetes. Diabetologia 67, 670-678 (2024)
Jumpertz von Schwartzenberg, R. ; Vazquez Arreola, E.* ; Sandforth, A. ; Hanson, R.L.* & Birkenfeld, A.L. Role of weight loss-induced prediabetes remission in the prevention of type 2 diabetes: Time to improve diabetes prevention. Diabetologia, DOI: 10.1007/s00125-024-06178-5 (2024)
Mooshage, C.M.* et al. A diminished sciatic nerve structural integrity is associated with distinct peripheral sensory phenotypes in individuals with type 2 diabetes. Diabetologia 67, 275-289 (2024)
Phillip, M.* et al. Correction to: Consensus guidance for monitoring individuals with islet autoantibody‑positive pre‑stage 3 type 1 diabetes. Diabetologia 67, 2012–2014 (2024)
Rauscher, F.G.* et al. Glucose tolerance and insulin resistance/sensitivity associate with retinal layer characteristics: The LIFE-Adult-Study. Diabetologia 67, 928-939 (2024)
Sharma, S. et al. Role of human plasma metabolites in prediabetes and type 2 diabetes from the IMI-DIRECT study. Diabetologia 67, 2804-2818 (2024)
Singh, T. et al. Caesarean section and risk of type 1 diabetes. Diabetologia, DOI: 10.1007/s00125-024-06176-7 (2024)
Villalba, A.* et al. A 3D atlas of the human developing pancreas to explore progenitor proliferation and differentiation. Diabetologia 67, 1066-1078 (2024)
Apaolaza Gallegos, S.P. ; Balcacean, D. ; Zapardiel-Gonzalo, J. & Rodriguez-Calvo, T. The extent and magnitude of islet T cell infiltration as powerful tools to define the progression to type 1 diabetes. Diabetologia 66, 1129-1141 (2023)
Blüher, M. ; Rosenstock, J.* ; Hoefler, J.* ; Manuel, R.* & Hennige, A.M.* Dose-response effects on HbA1c and bodyweight reduction of survodutide, a dual glucagon/GLP-1 receptor agonist, compared with placebo and open-label semaglutide in people with type 2 diabetes: A randomised clinical trial. Diabetologia, 13 (2023)
Cui, X.* et al. Pancreatic alpha cell glucagon-liver FGF21 axis regulates beta cell regeneration in a mouse model of type 2 diabetes. Diabetologia 66, 535-550 (2023)
Fan, M. ; Stephan, A.-J. ; Emmert-Fees, K. ; Peters, A. & Laxy, M. Health and economic impact of improved glucose, blood pressure and lipid control among German adults with type 2 diabetes: A modelling study. Diabetologia 66, 1693-1704 (2023)
Hummel, S. ; Friedl, N. ; Winkler, C. ; Ziegler, A.-G. & Achenbach, P. Presymptomatic type 1 diabetes and disease severity at onset. Reply to Schneider J, Gemulla G, Kiess W et al [letter]. Diabetologia 66, 2389-2390 (2023)
Hummel, S. et al. Children diagnosed with presymptomatic type 1 diabetes through public health screening have milder diabetes at clinical manifestation. Diabetologia 66, 1633-1642 (2023)
Li, J.H.* et al. Genome-wide association analysis identifies ancestry-specific genetic variation associated with acute response to metformin and glipizide in SUGAR-MGH. Diabetologia 66, 1260-1272 (2023)
Lorza-Gil, E. et al. Glucose-stimulated insulin secretion depends on FFA1 and Gq in neonatal mouse islets. Diabetologia 66, 1501-1515 (2023)
Luo, H. et al. Associations of plasma proteomics with type 2 diabetes and related traits: Results from the longitudinal KORA S4/F4/FF4 Study. Diabetologia 66, 1655-1668 (2023)
Lutter, D. et al. Skeletal muscle and intermuscular adipose tissue gene expression profiling identifies new biomarkers with prognostic significance for insulin resistance progression and intervention response. Diabetologia 66, 873-883 (2023)
Marzinotto, I.* et al. Islet Autoantibody Standardization Program: Interlaboratory comparison of insulin autoantibody assay performance in 2018 and 2020 workshops. Diabetologia 66, 897-912 (2023)
Nauck, M.A.* & Müller, T.D. Incretin hormones and type 2 diabetes. Diabetologia 66, 1780-1795 (2023)
Tschöp, M.H. ; Nogueiras, R.* & Ahrén, B.* Gut hormone-based pharmacology: Novel formulations and future possibilities for metabolic disease therapy. Diabetologia 66, 1796-1808 (2023)
Wewer Albrechtsen, N.J.* et al. 100 years of glucagon and 100 more. Diabetologia 66, 1378-1394 (2023)
Ziegler, A.-G. The countdown to type 1 diabetes: when, how and why does the clock start? Diabetologia 66, 1169-1178 (2023)
Fraszczyk, E.* et al. Epigenome-wide association study of incident type 2 diabetes: A meta-analysis of five prospective European cohorts. Diabetologia 65, 763-776 (2022)
Maalmi, H.* et al. Serum neurofilament light chain: A novel biomarker for early diabetic sensorimotor polyneuropathy. Diabetologia 66, 579-589 (2022)
Meyhöfer, S.* et al. Sleep deprivation prevents counterregulatory adaptation to recurrent hypoglycaemia. Diabetologia 65, 1212-1221 (2022)
Morgenstern, J.* et al. Correction to: Neuron-specific biomarkers predict hypo- and hyperalgesia in individuals with diabetic peripheral neuropathy. Diabetologia 65:257 (2022)
Ng, K.* et al. Quantifying the utility of islet autoantibody levels in the prediction of type 1 diabetes in children. Diabetologia 66, 93-104 (2022)
Sola-Gazagnes, A.* et al. Insulin allergy: A diagnostic and therapeutic strategy based on a retrospective cohort and a case–control study. Diabetologia 65, 1278-1290 (2022)
Weiss, A. et al. Progression likelihood score identifies substages of presymptomatic type 1 diabetes in childhood public health screening. Diabetologia 65, 93-104 (2022)
Weiss, A. et al. Correction to: Progression likelihood score identifies substages of presymptomatic type 1 diabetes in childhood public health screening. Diabetologia, DOI: 10.1007/s00125-022-05798-z (2022)
Woelfle, T.* et al. Health impact of seven herpesviruses on (pre)diabetes incidence and HbA1c: Results from the KORA cohort. Diabetologia 65, 1328-1338 (2022)
Assfalg, R. et al. Oral insulin immunotherapy in children at risk for type 1 diabetes in a randomised controlled trial. Diabetologia 64, 1079-1092 (2021)
Bediaga, N.G.* et al. Simplifying prediction of disease progression in pre-symptomatic type 1 diabetes using a single blood sample. Diabetologia, DOI: 10.1007/s00125-021-05523-2 (2021)
Gar, C. et al. The liver–alpha cell axis associates with liver fat and insulin resistance: A validation study in women with non-steatotic liver fat levels. Diabetologia 64, 512-520 (2021)
Gastaldelli, A.* ; Stefan, N. & Häring, H.-U. Liver-targeting drugs and their effect on blood glucose and hepatic lipids. Diabetologia 64, 1461-1479 (2021)
Gerst, F. et al. The hepatokine fetuin-A disrupts functional maturation of pancreatic beta cells. Diabetologia 64, 1358–1374 (2021)
Giroud, M. et al. HAND2 is a novel obesity-linked adipogenic transcription factor regulated by glucocorticoid signalling. Diabetologia 64, 1850-1865 (2021)
Johnson, R.K.* et al. Maternal food consumption during late pregnancy and offspring risk of islet autoimmunity and type 1 diabetes. Diabetologia 64, 1604-1612 (2021)
Johnson, S.B.* et al. First-appearing islet autoantibodies for type 1 diabetes in young children: Maternal life events during pregnancy and the child’s genetic risk. Diabetologia 64, 591-602 (2021)
Krischer, J.P.* et al. Characteristics of children diagnosed with type 1 diabetes before vs after 6 years of age in the TEDDY cohort study. Diabetologia 64, 2247-2257 (2021)
Morgenstern, J.* et al. Neuron-specific biomarkers predict hypo- and hyperalgesia in individuals with diabetic peripheral neuropathy. Diabetologia, DOI: 10.1007/s00125-021-05557-6 (2021)
Pistrosch, F.* et al. Rivaroxaban compared with low-dose aspirin in individuals with type 2 diabetes and high cardiovascular risk: A randomised trial to assess effects on endothelial function, platelet activation and vascular biomarkers. Diabetologia, DOI: 10.1007/s00125-021-05562-9 (2021)
Achenbach, P. et al. Heterogeneous islet autoantibody evolution trajectories in multi-site birth cohort studies. Diabetologia 63, 1, S160-S160 (2020)
Anand, V.* et al. Visualising heterogeneous islet autoantibody trajectories of children who develope type 1 diabetes from multi-site birth cohort studies. Diabetologia 63, 1, S101-S102 (2020)
Barovic, M. et al. Exploring islet amyloidosis in type 2 diabetes in metabolically profiled pancreatectomised surgical donors. Diabetologia 63, 1, S163-S164 (2020)
Bauer, I. et al. Maternal mental state correlates with maternal insulin sensitivity and interleukin-6 levels in late pregnancy. Diabetologia 63, 1, S211-S212 (2020)
Bovy, N.* et al. Long-term follow-up study of type 1 diabetes patients previously treated with IMCY-0098 or placebo in young adults with recent-onset type 1 diabetes. Diabetologia 63, 1, S26-S27 (2020)
Brings, S.* ; Fleming, T.* ; Herzig, S. ; Nawroth, P.P.* & Kopf, S.* Urinary cathepsin levels are predictive of the improvement of albuminuria and are associated with elevated excretion of free glucosepane. Diabetologia 63, 1, S384-S385 (2020)
Cobo-Vuilleumier, N.* et al. Lrh1/nr5a2 conveys the anti-diabetic effects of the agonist bl001 and promotes alpha-to-beta-cell conversion in streptozotocin-treated mice. Diabetologia 63, 1, S182-S183 (2020)
De Luca, C.* et al. Factors affecting function of human pancreatic islets after isolation. Diabetologia 63, 1, S179-S179 (2020)
Gallegos, P.A. et al. Presence of markers associated with viral infections in the pancreas before and after onset of type 1 diabetes. Diabetologia 63, 1, S157-S157 (2020)
Ghalwash, M.* et al. Optimal ages for screening for type 1 diabetes risk in children. Diabetologia 63, 1, S181-S181 (2020)
Hummel, J. et al. Brain insulin sensitivity is modulated by menstrual cycle. Diabetologia 63, 1, S14-S14 (2020)
Jall, S. et al. Pharmacological targeting of α3β4 nicotinic receptors improves peripheral insulin sensitivity in mice with diet-induced obesity. Diabetologia 63, 1236-1247 (2020)
Khamis, A.* et al. Pnliprp1 hypermethylation in human exocrine pancreas reveals a link between diabetes and pancreatic cancer. Diabetologia 63, 1, S109-S109 (2020)
Koivula, R.W.* et al. The role of physical activity in metabolic homeostasis before and after the onset of type 2 diabetes: An IMI DIRECT study. Diabetologia 63, 744-756 (2020)
Koivula, R.W.* et al. Correction to: The role of physical activity in metabolic homeostasis before and after the onset of type 2 diabetes: an IMI DIRECT study (Diabetologia, (2020), 63, 4, (744-756), 10.1007/s00125-019-05083-6). Diabetologia 64, 260-261 (2020)
Kullmann, S. et al. Empagliflozin improves insulin sensitivity of the hypothalamus in humans with prediabetes. Diabetologia 63, 1, S13-S14 (2020)
Kwon, B.* et al. A visual analytics method to explore the evolution of autoantibodies during progression to type 1 diabetes in multi-site birth cohort studies. Diabetologia 63, 1, S159-S159 (2020)
Lamprinou, A.* et al. Evaluation of determinants of hepatic insulin clearance: a Mendelian randomisation study. Diabetologia 63, 1, S36-S37 (2020)
Marinicova, Z. et al. Presentation of insulin granule derived peptides on MHC I in Enterovirus-infected beta cells and type 1 diabetes. Diabetologia 63, 1, S111-S111 (2020)
Mattila, M.* et al. Plasma ascorbic acid and the risk of islet autoimmunity and type 1 diabetes: The TEDDY study. Diabetologia 63, 278-286 (2020)
Oquendo, M.B. et al. Comparison between in vitro differentiation of pancreatic and subcutaneous adipocytes of subjects with normal glucose tolerance. Diabetologia 63, 1, S254-S255 (2020)
Scarale, M.* et al. Circulating metabolites significantly improve the prediction of renal dysfunction in type 2 diabetes. Diabetologia 63, 1, S3-S3 (2020)
Scarale, M.* et al. Building clinical risk score systems for predicting all-cause and cardiovascular-specific mortality among type 2 diabetes patients. Diabetologia 63, S3-S4 (2020)
Suleiman, M.* et al. Glucose-lowering therapy and ex-vivo beta cell function in type 2 diabetes. Diabetologia 63, 1, S196-S196 (2020)
van Krieken, P.P.* ; Odermatt, T.S.* ; Blüher, M. ; Wueest, S.* & Konrad, D.* Oncostatin M inhibits browning of white adipose tissue via gp130 signalling. Diabetologia 63, 1, S21-S22 (2020)
Vasiljevic, J. ; Torkko, J.M. ; Knoch, K.-P. & Solimena, M. The making of insulin in health and disease. Diabetologia 63, 1981-1989 (2020)
Vasiljevic, J. et al. Post-transcriptional co-regulation of insulin secretory granule proteins. Diabetologia 63, 1, S7-S8 (2020)
Vosseler, A. et al. Postprandial thermogenesis is reduced in obesity. Diabetologia 63, 1, S258-S258 (2020)
Wagner, L. et al. Exercise changes neuronal processing of food cues in sedentary overweight and obese adults. Diabetologia 63, 1, S98-S98 (2020)
Wigger, L.* et al. Cross-sectional multi-omics insight from islet and plasma samples into the progression to type 2 diabetes in metabolically profiled pancreatectomised surgical donors. Diabetologia 63, 1, S106-S106 (2020)
Ziegler, A.-G. & Bonifacio, E. Why is the presence of autoantibodies against GAD associated with a relatively slow progression to clinical diabetes? Diabetologia, DOI: 10.1007/s00125-020-05175-8 (2020)
Eugster, A.* et al. Cytoplasmic ends of tetraspanin 7 harbour epitopes recognised by autoantibodies in type 1 diabetes. Diabetologia 62, 805-810 (2019)
Fritsche, L. et al. Gestational weight gain but not gestational diabetes associate with altered heart rate variability in 2 year old children. Diabetologia 62, S447-S448 (2019)
Gallegos, P.A. et al. Enterovirus as triggers of disease? New insights from autoantibody positive and type 1 diabetic nPOD donors. Diabetologia 62, S203-S203 (2019)
Gerst, F. et al. Fetuin-A inhibits functional maturation of insulin secreting beta cells. Diabetologia 62, S228-S228 (2019)
Gil, E.L. et al. Expression of FFA2 and FFA3 and their role in human, mouse and rat insulin secreting cells. Diabetologia 62, S213-S213 (2019)
Henke, C. et al. Mechanisms of age-dependent amplification of insulin secretion. Diabetologia 62, S219-S220 (2019)
Kahl, S.* et al. Empagliflozin as metabolically active compound for treatment of non-alcoholic fatty liver disease in type 2 diabetes. Diabetologia 62, S124-S124 (2019)
Kaiser, G. et al. Stimulation of FFA1/GPR40 raises the intracellular Ca2+ concentration via activation of TrpM3 channels in beta cells. Diabetologia 62, S208-S208 (2019)
Klymenko, O.* et al. HDAC5 regulates IL-6 transcription and enhances insulin signalling in skeletal muscle. Diabetologia 62, S136-S136 (2019)
Koivula, R.W.* et al. Discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes: Descriptive characteristics of the epidemiological studies within the IMI DIRECT Consortium. Diabetologia 62, 1601-1615 (2019)
Marchetti, P.* et al. Fostering improved human islet research: A European perspective. Diabetologia 62, 1514-1516 (2019)
Oquendo, M.B. et al. Characterisation of the gene expression of pancreatic preadipocytes and adipocytes from patients with different metabolic status. Diabetologia 62, S295-S295 (2019)
Schreiner, B.* et al. Perinodal fat cells differ from other fat cell locations regarding fat accumulation, expression of cytokines, chemoattractants, adhesion molecules and ECM components. Diabetologia 62, S309-S310 (2019)
Siegel-Axel, D. et al. Pancreatic fat cells and fetuin-A/palmitate stimulate monocyte migration and remodelling of extracellular matrix. Diabetologia 62, S318-S318 (2019)
Straub, L.G.* et al. Antioxidants protect against diabetes by improving glucose homeostasis in mouse models of inducible insulin resistance and obesity. Diabetologia 62, 2094-2105 (2019)
Timpel, P.* ; Harst, L.* ; Reifegerste, D.* ; Weihrauch-Blüher, S.* & Schwarz, P.E. What should governments be doing to prevent diabetes throughout the life course? Diabetologia 62, 1842-1853 (2019)
Ullrich, S. et al. Aldolase B is a marker of functional immaturity of type 2 diabetic beta cells. Diabetologia 62, S230-S230 (2019)
Van Rampelbergh, J.* et al. Phase Ib clinical trial of IMCY-0098 in young adults with recent-onsent type 1 diabetes. Diabetologia 62, S352-S353 (2019)
Wittenbecher, C.* ; Kuxhaus, O.* ; Boeing, H.* ; Stefan, N. & Schulze, M.B.* Associations of short stature and components of height with incidence of type 2 diabetes: Mediating effects of cardiometabolic risk factors. Diabetologia 62, 2211-2221 (2019)
Achenbach, P. et al. Autoantibodies to N-terminally truncated GAD improve clinical phenotyping of individuals with adult-onset diabetes: Action LADA 12. Diabetologia 61, 1644-1649 (2018)
Gerst, F. et al. Fetuin-A impairs islet differentiation and function via inhibition of TGFbeta-1 signalling. Diabetologia 61, S205-S206 (2018)
Gil, E.L. et al. Acetate stimulates insulin secretion of human pancreatic microislets. Diabetologia 61, S122-S122 (2018)
Heni, M. et al. Brain insulin action stimulates pancreatic insulin secretion: Results from hyperglycaemic clamps. Diabetologia 61, S72-S72 (2018)
Herder, C.* et al. A systemic inflammatory signature reflecting crosstalk between innate and adaptive immunity is associated with polyneuropathy: KORA F4/FF4 Study. Diabetologia 61, S467-S467 (2018)
Honsek, C.* et al. Fibre supplementation for the prevention of type 2 diabetes and improvement of glucose metabolism: The randomised controlled Optimal Fibre Trial (OptiFiT). Diabetologia 61, 1295-1305 (2018)
Kappler, L.* et al. Linking of bioenergetic function of mitochondria to tissue-specific molecular fingerprints in mice and humans. Diabetologia 61, S271-S271 (2018)
Knoch, K.-P. et al. CVB5 proteases 2A reduces insulin granule maturation only indirect. Diabetologia 61, S150-S150 (2018)
Kullmann, S. et al. Insulin influences mindset-induced brain response and behaviour on portion size selection for lunch. Diabetologia 61, S336-S336 (2018)
Long, A.E.* et al. Characteristics of slow progression to diabetes in multiple islet autoantibody-positive individuals from five longitudinal cohorts: The SNAIL study. Diabetologia 61, 1484–1490 (2018)
Mathieu, C.* ; Lahesmaa, R.* ; Bonifacio, E. ; Achenbach, P. & Tree, T.* Immunological biomarkers for the development and progression of type 1 diabetes. Diabetologia 61, 2252-2258 (2018)
Niersmann, C.* et al. Omentin-induced secretion of proteins by primary human adipocytes and stimulation of the innate immune system. Diabetologia 61, S254-S255 (2018)
Pitchika, A. et al. Associations of maternal type 1 diabetes with childhood adiposity and metabolic health in the offspring: A prospective cohort study. Diabetologia 61, 2319–2332 (2018)
Saussenthaler, S.* et al. Interindividual susceptibility to type 2 diabetes in mice: Hepatic transcriptome and DNA methylome profiling. Diabetologia 61, S259-S259 (2018)
Siegel-Axel, D. et al. Differences in extracellular matrix expression in pancreatic fat cells of non-diabetic, pre-diabetic and diabetic individuals. Diabetologia 61, S289-S290 (2018)
Solimena, M. et al. Systems biology of the IMIDIA biobank from organ donors and pancreatectomised patients defines a novel transcriptomic signature of islets from individuals with type 2 diabetes. Diabetologia 61, 641–657 (2018)
Stadion, M.* et al. The impact of cilia-genes on pancreatic beta cell replication and the risk of type 2 diabetes. Diabetologia 61, S194-S194 (2018)
Weitz, J.R.* et al. Mouse pancreatic islet macrophages use locally released ATP to monitor beta cell activity. Diabetologia 61, 182–192 (2018)
Willmann, C. et al. Effects of increased fiber and reduced red meat intake, combined with caloric restriction, on cardiometabolic risk: A randomised and controlled dietary intervention study. Diabetologia 61, S78-S78 (2018)
Bonifacio, E.* et al. Rebranding asymptomatic type 1 diabetes: The case for autoimmune beta cell disorder as a pathological and diagnostic entity. Diabetologia 60, 35-38 (2017)
Dawed, A.Y.* et al. GLP-1 receptor variants markedly differentiate glycaemic response to GLP-1 receptor agonists: A DIRECT study. Diabetologia 60, S393-S393 (2017)
Elding Larsson, H.* et al. Pandemrix® vaccination is not associated with increased risk of islet autoimmunity or type 1 diabetes in the TEDDY study children. Diabetologia 61, 193–202 (2017)
Eriksson, O.* et al. First-in-class PET tracer for the glucagon receptor. Diabetologia 60, S400-S400 (2017)
Gerst, F. et al. Metabolic crosstalk between fatty pancreas and fatty liver: Effects on local inflammation and insulin secretion. Diabetologia 60, 2240-2251 (2017)
Herder, C.* et al. Higher serum levels of omentin-1 are associated with increases in glycaemia and incident type 2 diabetes: KORA F4/FF4 study. Diabetologia 60, S270-S270 (2017)
Kemter, E.* et al. INS-eGFP transgenic pigs: A novel reporter system for studying maturation, growth and vascularisation of neonatal islet-like cell clusters. Diabetologia 60, 1152-1156 (2017)
Kleinwort, K.J.H.* et al. Retinopathy with central oedema in an INSC94Y transgenic pig model of long-term diabetes. Diabetologia 60, 1541–1549 (2017)
Laperrousaz, E.* et al. Lipoprotein lipase in hypothalamus is a key regulator of body weight gain and glucose homeostasis in mice. Diabetologia 60, 1314-1324 (2017)
Lönnrot, M.* et al. Respiratory infections are temporally associated with initiation of type 1 diabetes autoimmunity: The TEDDY study. Diabetologia 60, 1931-1940 (2017)
Lönnrot, M.* et al. Correction to: Respiratory infections are temporally associated with initiation of type 1 diabetes autoimmunity: The TEDDY study. Diabetologia 61, 254-254 (2017)
Lutz, S.Z. et al. Complex interplay between androgen, estrogen and insulin receptor gene expression in prostate cancer depending on diabetes status. Diabetologia 60, S565-S565 (2017)
Molnos, S. et al. Metabolite ratios as potential biomarkers for type 2 diabetes: A DIRECT study. Diabetologia 61, 117-129 (2017)
Morgenstern, J.* et al. Loss of glyoxalase 1 in various mammalian cells is associated with an increased resistance against environmental stressors. Diabetologia 60, S507-S508 (2017)
Neukam, M. et al. A novel method for the background-free purification of age-distinct insulin secretory granules for proteomic and lipidomic analyses. Diabetologia 60, S23-S23 (2017)
Sánchez-Garrido, M.A. et al. GLP-1/glucagon receptor co-agonism for treatment of obesity. Diabetologia 60, 1851–1861 (2017)
Schmid, V.* et al. Non-alcoholic fatty liver disease and impaired proinsulin conversion as newly identified predictors of the long-term non-response to a lifestyle intervention for diabetes prevention: Results from the TULIP study. Diabetologia 60, 2341-2351 (2017)
Siegel-Axel, D. et al. The 'fatty kidney': Crosstalk of renal sinus fat with glomerular cells under the influence of the hepatokine fetuin-A. Diabetologia 60, S483-S483 (2017)
Stirm, L. ; Fritsche, L. ; Fritsche, A. ; Häring, H.-U. & Staiger, H. Apelinergic system in placenta of women with gestational diabetes. Diabetologia 60, S44-S44 (2017)
von Toerne, C. et al. Peptide serum markers in islet autoantibody-positive children. Diabetologia 60, 287-295 (2017)
't Hart, L.M.* et al. A metabolite ratio associates with measures of insulin secretion and altered risk of type 2 diabetes; a DIRECT study. Diabetologia 59, S142-S143 (2016)
Adamski, J. Key elements of metabolomics in the study of biomarkers of diabetes. Diabetologia 59, 2497-2502 (2016)
Anastasiou, V. et al. Aldehyde dehydrogenase activity is necessary for beta cell development and functionality in mice. Diabetologia 59, 139-150 (2016)
Berti, L. ; Raedle, B. ; Häring, H.-U. ; Hrabě de Angelis, M. & Staiger, H. Mitogenic activity of the metabolically relevant hepatokine FGF21 in human carcinoma cells. Diabetologia 59, S274-S274 (2016)
Bohn, B.* et al. Are recommended goals for secondary prevention of myocardial infarction or stroke achieved in real life? A German/Austrian DPV analysis of 29,325 patients with type 2 diabetes. Diabetologia 59, S550-S550 (2016)
Catani, M.* et al. Isolation of human monoclonal autoantibodies derived from pancreatic lymph node and peripheral blood B cells of islet autoantibody-positive patients. Diabetologia 59, 294-298 (2016)
Chhabra, N.F. et al. Systemic metabolic effects exerted by a point mutation in the RED subdomain of PAX6. Diabetologia 59, S259-S259 (2016)
Endesfelder, D. et al. A novel approach for the analysis of longitudinal profiles reveals delayed progression to type 1 diabetes in a subgroup of multiple-islet-autoantibody-positive children. Diabetologia 59, 2172-2180 (2016)
Fall, T.* et al. Non-targeted metabolomics combined with genetic analyses identifies bile acid synthesis and phospholipid metabolism as being associated with incident type 2 diabetes. Diabetologia 59, 2114-2124 (2016)
Fütterer, M. et al. Dll1-and Dll4-mediated Notch signalling in adult pancreatic beta cells is essential for the structural integrity of islets and maintenance of glucose homeostasis. Diabetologia 59, S188-S188 (2016)
Gerst, F. et al. Crosstalk of fatty liver with fatty pancreas impairs islet function in humans. Diabetologia 59, S217-S217 (2016)
Hawlitschek, C.* et al. Elevated glutamate and branched chain amino acid levels in overweight/obese individuals: Links to insulin resistance and visceral adiposity. Diabetologia 59, S162-S162 (2016)
Heni, M. et al. Interaction between the obesity-risk gene FTO and the dopamine D2 receptor gene ANKK1/TaqIA on insulin sensitivity. Diabetologia 59, 1-10 (2016)
Herder, C.* et al. Increased serum levels of interleukin-1 receptor antagonist (IL-1ra) precede coronary heart disease: Meta-analysis of 4 prospective cohort studies. Diabetologia 59, S527-S527 (2016)
Kluth, O.* et al. Identification and functional characterisation of diabetes genes in mice. Diabetologia 59, S168-S168 (2016)
Kopf, S.* et al. Impaired lung function as a diabetes related complication. Diabetologia 59, S521-S521 (2016)
Krueger, J.* et al. Genome wide meta-analysis identifies novel regulators of circulating serum progranulin. Diabetologia 59, S176-S177 (2016)
Migliorini, A. ; Roscioni, S. & Lickert, H. Targeting insulin-producing beta cells for regenerative therapy. Diabetologia 59, 1838-1842 (2016)
Much, D. et al. Lactation is associated with altered metabolomic signatures in women with gestational diabetes. Diabetologia 59, 2193-2202 (2016)
Much, D. et al. Lactation is associated with altered metabolomic signatures in women with gestational diabetes. Diabetologia 59, S187-S187 (2016)
Müller, A. et al. Ultrastructural analysis of insulin secretory granule ageing by super resolution and transmission electron microscopy. Diabetologia 59, S194-S195 (2016)
Neukam, M. ; Müller, A. ; Sönmez, A. & Solimena, M. FLIM-based pH measurements reveal incretin-induced rejuvenation of aged insulin secretory granules. Diabetologia 59, S193-S194 (2016)
Osterhoff, M.A.* et al. Specific phospholipids are differently associated to human visceral and non-visceral adipose tissue depending on the inflammatory state in the NUGAT Twin study. Diabetologia 59, S67-S67 (2016)
Quarta, C. ; Sánchez-Garrido, M.A. ; Tschöp, M.H. & Clemmensen, C. Renaissance of leptin for obesity therapy. Diabetologia 59, 920-927 (2016)
Radovic, B.* et al. Lysosomal acid lipase regulates VLDL synthesis and insulin sensitivity in mice. Diabetologia 59, 1743-1752 (2016)
Rottenkolber, M.* et al. Targeted metabolomics to predict the primary success of metformin monotherapy in type 2 diabetes. Diabetologia 59, S127-S127 (2016)
Schmid, V. et al. Liver fat content and insulin secretion failure are associated with the long-term success of a lifestyle intervention to prevent type 2 diabetes: Results of the TULIP study. Diabetologia 59, S171-S171 (2016)
Siegel-Axel, D. et al. The interplay of fatty liver with fatty pancreas accenuates local islet inflammation in humans. Diabetologia 59, S79-S79 (2016)
Solimena, M. & Schulte, A.M.* System biology of the IMIDIA biobank from organ donors and pancreatectomised patients defines the transcriptomic signature of type 2 diabetes islets. Diabetologia 59, S169-S169 (2016)
Stirm, L. et al. miRNA signatures in maternal whole blood cells of women with gestational diabetes. Diabetologia 59, S47-S47 (2016)
Teperino, R. et al. Polycomb controls metabolic homeostasis through a novel liver-to-adipose axis. Diabetologia 59, S307-S307 (2016)
Ustunel, B.E.* et al. Transforming growth factor beta-like stimulated clone 22 D4 promotes diabetic hyperglycaemia and insulin resistance. Diabetologia 59, S234-S234 (2016)
von Toerne, C. et al. MASP1, THBS1, GPLD1 and ApoA-IV are novel biomarkers associated with prediabetes: The KORA F4 study. Diabetologia 59, 1882-1892 (2016)
Walther, D.* et al. Tetraspanin 7 autoantibodies in type 1 diabetes. Diabetologia 59, 1973-1976 (2016)
Wood, A.R.* et al. Variants in the FTO and CDKAL1 loci have recessive effects on risk of obesity and type 2 diabetes, respectively. Diabetologia 59, 1214-1221 (2016)
Affourtit, C.* ; Barlow, J.* ; Jensen, V.H.* & Jastroch, M. Palmitate-induced impairment of glucose-stimulated insulin secretion by pancreatic beta cells is disconnected from concomitant mitochondrial respiratory defects. Diabetologia 58, S228-S229 (2015)
Böhm, A. et al. Reduced and adverse metabolic response to supervised 8-week endurance exercise in a group at high risk for type 2 diabetes. Diabetologia 58, S258 (2015)
Chmiel, R. et al. Progression from single to multiple islet autoantibodies often occurs soon after seroconversion: Implications for early screening. Diabetologia 58, 411-413 (2015)
Gerst, F. et al. The hepatokine fetuin-A has TLR4 dependent and independent effects in islets. Diabetologia 58, S45 (2015)
Gerst, F. et al. Protein kinase Cδ regulates nuclear export of FOXO1 through phosphorylation of the chaperone 14-3-3ζ. Diabetologia 58, 2819-2831 (2015)
Giannopoulou, E.Z. et al. Islet autoantibody phenotypes and incidence in children at increased risk for type 1 diabetes. Diabetologia 58, 2317-2323 (2015)
Hansen, J.S.* et al. Type 2 diabetes alters metabolic and transcriptional signatures of glucose and amino acid metabolism during exercise and recovery. Diabetologia 58, 1845-1854 (2015)
Heni, M.* et al. Associations of glucagon-like peptide 1 with food processing in the brain are present in lean and obese humans. Diabetologia 58, S305 (2015)
Ivanova-Cederstroem, A. et al. Generation of the transgenic INS-SNAP (SOFIA) pig for the high-throughput high-content study of insulin granule biogenesis and turnover in isolated islets. Diabetologia 58, S217 (2015)
Keyhani-Nejad, F.* et al. Nutritional strategy to prevent fatty liver and insulin resistance independent from obesity by reducing glucose-dependent insulinotropic polypeptide responses in mice. Diabetologia 58, 374-383 (2015)
Klüppelholz, B.* et al. Association of subclinical inflammation with deterioration of glycaemia before the diagnosis of type 2 diabetes: The KORA S4/F4 study. Diabetologia 58, 2269-2277 (2015)
Krischer, J.P.* et al. The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: The TEDDY study. Diabetologia 58, 980-987 (2015)
Kröger, J.* et al. Erythrocyte membrane fatty acid fluidity and risk of type 2 diabetes in the EPIC-Potsdam study. Diabetologia 58, 282-289 (2015)
Looker, H.C.* et al. Protein biomarkers for the prediction of cardiovascular disease in type 2 diabetes. Diabetologia 58, 1363-1371 (2015)
Nowotny, B.* et al. Low-energy diets differing in fibre, red meat and coffee intake equally improve insulin sensitivity in type 2 diabetes: A randomised feasibility trial. Diabetologia 58, 255-264 (2015)
Panse, M.* ; Kaiser, G. ; Gerst, F. ; Häring, H.-U. & Ullrich, S. Downregulation of TxNIP under glucolipotoxic conditions in insulin secreting cells. Diabetologia 58, S232 (2015)
Petzold, A. et al. Coxsackievirus B5 infection and CVB5 proteases 2A and 3C both increase caspase 3/7 activity independently from apoptosis and reduce insulin granule cargoes in beta cells. Diabetologia 58, S229-S230 (2015)
Schwenk, R.W.* et al. GLP-1–oestrogen attenuates hyperphagia and protects from beta cell failure in diabetes-prone New Zealand Obese (NZO) mice. Diabetologia 58, 604-614 (2015)
Speier, S. et al. Calcium independent functional compensation of beta cells predominates islet mass adaptation in diet induced insulin resistance. Diabetologia 58, S278 (2015)
Stefan, N. et al. A high-risk phenotype associates with reduced improvement in glycaemia during a lifestyle intervention in prediabetes. Diabetologia 58, 2877-2884 (2015)
Stemmer, K. et al. FGF21 is not required for glucose homeostasis, ketosis or tumour suppression associated with ketogenic diets in mice. Diabetologia 58, 2414-2423 (2015)
Stertmann, J. et al. Comparative biology of porcine and human islets in situ and after xenotransplantation in vivo. Diabetologia 58, S251 (2015)
van Waateringe, R.P.* et al. Skin autofluorescence is related to tobacco smoke and nicotine exposure. Diabetologia 58, S155-S156 (2015)
Wagner, R. et al. SNP x SNP interactions in the VPS13C/C2CD4A/C2CD4B locus modulate diabetes risk. Diabetologia 58, S142 (2015)
Yousri, N.A.* et al. A systems view of type 2 diabetes-associated metabolic perturbations in saliva, blood and urine at different timescales of glycaemic control. Diabetologia 58, 1855-1867 (2015)
Yousri, N.A.* et al. Erratum to: A systems view of type 2 diabetes-associated metabolic perturbations in saliva, blood and urine at different timescales of glycaemic control. Diabetologia 58, 2199 (2015)
Ziegler, D.* et al. Increased prevalence of cardiac autonomic dysfunction at different degrees of glucose intolerance in the general population: The KORA S4 survey. Diabetologia 58, 1118-1128 (2015)
Bender, C.* ; Schlosser, M.* ; Christen, U.* ; Ziegler, A.-G. & Achenbach, P. GAD autoantibody affinity in schoolchildren from the general population. Diabetologia 57, 1911-1918 (2014)
Breitfeld, J.* et al. Genome wide meta-analysis highlights the role of genetic variation in RARRES2 in regulation of circulating serum chemerin. Diabetologia 57, S67-S68 (2014)
Gaulton, K.J.* ; Morris, A.P.* ; McCarthy, M.I.* & DIAGRAM Consortium (Gieger, C. ; Grallert, H. ; Klopp, N. ; Illig, T. ; Müller-Nurasyid, M. ; Peters, A.) FOXA2 bound sites are enriched for type 2 diabetes risk variants. Diabetologia 57, S66 (2014)
Gerst, F. ; Kaiser, G. ; Stefan, N. ; Häring, H.-U. & Ullrich, S. The hepatokine fetuin-A triggers inflammation without inducing cell death but improves cAMP-dependent insulin secretion of pancreatic islets. Diabetologia 57, S184 (2014)
Gutierrez-Aguilar, R.* et al. The role of the transcription factor ETV5 in insulin exocytosis. Diabetologia 57, 383-391 (2014)
Herder, C.* et al. Serum omentin is associated with lipid levels, but not with glucose tolerance and type 2: KORA F4 study. Diabetologia 57, S308 (2014)
Kaiser, G. et al. Defective compensatory insulin secretion causes HFD-induced glucose intolerance in mice with point mutation in free fatty acid receptor 1. Diabetologia 57, S172 (2014)
Klingler, C.* et al. Lysophosphatidylcholines as regulators of gene expression in human skeletal muscle. Diabetologia 57, S272 (2014)
Koivula, R.W.* et al. Discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes: Rationale and design of the epidemiological studies within the IMI DIRECT Consortium. Diabetologia 57, 1132-1142 (2014)
Linder, K. et al. Maternal insulin sensitivity is associated with oral glucose-induced changes in fetal brain activity. Diabetologia 57, 1192-1198 (2014)
Morris, A.P.* et al. Fine-mapping type 2 diabetes susceptibility loci with high-density imputation. Diabetologia 57, S50-S51 (2014)
Nejad, F.K.* et al. A high fat diet during pregnancy and lactation affects the metabolic fate of Gipr-/- mice via hypothalamic insulin signalling and DNA-methylation of lipid metabolism genes. Diabetologia 57, S41 (2014)
Peter, A. et al. PNPLA3 variant I148M is associated with altered hepatic lipid composition in humans. Diabetologia 57, 2103-2107 (2014)
Peter, A. et al. The hepatokine betatrophin is increased in nonalcoholic fatty liver disease and may affect insulin secretion in prediabetes. Diabetologia 57, S294 (2014)
Raab, J. et al. Prevalence of vitamin D deficiency in pre-type 1 diabetes and its association with disease progression. Diabetologia 57, 902-908 (2014)
Schlosser, M.* et al. Combined appearance of autoantibodies against GAD, IA-2, insulin and ZnT8 in the islet autoantibody standardisation program 2013 proficiency workshop. Diabetologia 57, S145 (2014)
Siegel-Axel, D. et al. The mRNA expression and release of (pro)-inflammatory and angiogenic factors in perivascular fat cells is influenced by fetuin-A via different signalling pathways. Diabetologia 57, S310 (2014)
Siegel-Axel, D.I. et al. Fetuin-a influences vascular cell growth and production of proinflammatory and angiogenic proteins by human perivascular fat cells. Diabetologia 57, 1057-1066 (2014)
Teutsch, C.A.* et al. Detection of free fatty acid receptor 1 expression: The critical role of negative and positive controls. Diabetologia 57, 776-780 (2014)
Winkler, C. et al. Feature ranking of type 1 diabetes susceptibility genes improves prediction of type 1 diabetes. Diabetologia 57, 2521-2529 (2014)
Winkler, C. et al. Erratum to: Feature ranking of type 1 diabetes susceptibility genes improves prediction of type 1 diabetes. Diabetologia 58, 206 (2014)
Achenbach, P. et al. Characteristics of rapid vs slow progression to type 1 diabetes in multiple islet autoantibody-positive children. Diabetologia 56, 1615-1622 (2013)
Albrechtsen, A.* et al. Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes. Diabetologia 56, 298-310 (2013)
Baerenwald, D.A.* et al. Multiple functional polymorphisms in the G6PC2 gene contribute to the association with higher fasting plasma glucose levels. Diabetologia 56, 1306-1316 (2013)
Boehm, A.A. et al. Metabolic profiling of cultured human adipocytes from metabolically malign versus benign obese individuals. Diabetologia 56, S331 (2013)
Brady, I.* et al. Biomarkers for prediction of CVD in type 2 diabetes. Diabetologia 56, S10-S11 (2013)
Colombo, M.* et al. Metabolic predictors of CVD in type 2 diabetes. Diabetologia 56, S539 (2013)
Heni, M. et al. Variation in the obesity risk gene FTO determines the postprandial cerebral processing of food stimuli. Diabetologia 56, S294 (2013)
Herder, C.* et al. Association of subclinical inflammation with polyneuropathy in the older population: KORA F4 study. Diabetologia 56, S500 (2013)
Kaiser, G. et al. Regulation of Forkhead box O1 (FOXO1) by protein kinase B and glucocorticoids: Different mechanisms of induction of beta cell death in vitro. Diabetologia 56, 1587-1595 (2013)
Kantartzis, K. et al. The change in plasma triglycerides during an OGTT strongly predicts nonalcoholic fatty liver disease and the effectiveness of a lifestyle intervention to reduce liver fat. Diabetologia 56, S323 (2013)
Keyhani-Nejad, F.* et al. High glycaemic index (GI) diet induced hepatic fat accumulation and insulin resistance is associated with high glucose-dependent insulinotropic polypeptide (GIP) secretion. Diabetologia 56, S267 (2013)
Kowall, B.* ; Peters, A. ; Thorand, B. ; Rathmann, W.* & Meisinger, C. Associations between longevity of parents and glucose regulation in their offspring: The KORA S4/F4 study. Diabetologia 56, 268-274 (2013)
Kowall, B.* et al. In the grey zone of type 2 diabetes prediction: Can we separate poorly discriminated incident cases and non-cases? Diabetologia 56, S171 (2013)
Lagou, V.* et al. Pleiotropic effects on lipid levels and obesity identified in multi-trait meta-analysis of genome-wide association studies (GWAS) of type 2 diabetes related traits. Diabetologia 56, S60 (2013)
Lee, H.S.* et al. Next-generation sequencing for viruses in children with rapid-onset type 1 diabetes. Diabetologia 56, 1705-1711 (2013)
Linder, K.* et al. Maternal insulin resistance affects foetal brain activity. Diabetologia 56, S71-S72 (2013)
Ly, A. et al. Retinal proteome alterations in a mouse model of type 2 diabetes. Diabetologia 57, 192-203 (2013)
Ma, R.C.* et al. Genome-wide association study in a Chinese population identifies a susceptibility locus for type 2 diabetes at 7q32 near PAX4. Diabetologia 56, 1291-1305 (2013)
Meisinger, C. et al. Serum potassium is associated with prediabetes and newly diagnosed diabetes in hypertensive adults from the general population: The KORA F4-study. Diabetologia 56, 484-491 (2013)
Sartorius, T. et al. Insulin action in the brain depends on whole-body insulin sensitivity. Diabetologia 56, S297 (2013)
Schipf, S.* et al. Regional differences in the incidence of known type 2 diabetes mellitus in 45-74 years old individuals: Results from five population-based studies in Germany. Diabetologia 56, S126-S127 (2013)
Schunk, M. et al. Health-related quality of life in adults with and without type 2 diabetes: Results of a pooled analysis of German population-based cohort studies. Diabetologia 56, S57 (2013)
Stienstra, R.* & Stefan, N. Tipping the inflammatory balance: Inflammasome activation distinguishes metabolically unhealthy from healthy obesity. Diabetologia 56, 2343-2346 (2013)
Thiering, E. et al. Long-term exposure to traffic-related air pollution and insulin resistance in children: Results from the GINIplus and LISAplus birth cohorts. Diabetologia 56, 1696-1704 (2013)
Wagner, R. et al. Family history of diabetes is associated with higher risk for prediabetes: A multicentre analysis from the German Center for Diabetes Research. Diabetologia 56, 2176-2180 (2013)
Williams, A.J.K.* et al. N-terminally truncated GAD discriminates progression in GAD antibody positive relatives of patients with type 1 diabetes. Diabetologia 56, S17 (2013)
Ziegler, D.* et al. Prevalence and risk factors of cardiac autonomic nerve dysfunction in the elderly population with diabetes and prediabetes: The KORA S4 survey. Diabetologia 56, S492 (2013)
Heni, M.* et al. Nasal insulin changes peripheral insulin sensitivity simultaneously with altered activity in homeostatic and reward-related human brain regions. Diabetologia 55, 1773-1782 (2012)
Howson, J.M.M.* et al. Genetic association of zinc transporter 8 (ZnT8) autoantibodies in type 1 diabetes cases. Diabetologia 55, 1978-1984 (2012)
Montonen, J.* et al. Body iron stores and risk of type 2 diabetes: Results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study. Diabetologia 55, 2613-2621 (2012)
Rittig, K.* et al. The secretion pattern of perivascular fat cells is different from that of subcutaneous and visceral fat cells. Diabetologia 55, 1514-1525 (2012)
Schulze, M.B.* et al. Body adiposity index, body fat content and incidence of type 2 diabetes. Diabetologia 55, 1660-1667 (2012)
Stöckl, D. et al. Age at menarche is associated with prediabetes and diabetes in women (aged 32-81 years) from the general population: The KORA F4 study. Diabetologia 55, 681-688 (2012)
Wagner, R.* et al. Exercise-induced albuminuria is associated with perivascular renal sinus fat in individuals at increased risk of type 2 diabetes. Diabetologia 55, 2054-2058 (2012)
Ziegler, A.-G. ; Bonifacio, E.* & BABYDIAB-BABYDIET Study Group (*) Age-related islet autoantibody incidence in offspring of patients with type 1 diabetes. Diabetologia 55, 1937-1943 (2012)
Hivert, M.F.* et al. Insulin resistance influences the association of adiponectin levels with diabetes incidence in two population-based cohorts: The Cooperative Health Research in the Region of Augsburg (KORA) S4/F4 study and the Framingham Offspring Study. Diabetologia 54, 1019-1024 (2011)
Jafar-Mohammadi, B.* et al. A role for coding functional variants in HNF4A in type 2 diabetes susceptibility. Diabetologia 54, 111-119 (2011)
Kiefer, F.W.* et al. Osteopontin deficiency protects against obesity-induced hepatic steatosis and attenuates glucose production in mice. Diabetologia 54, 2132-2142 (2011)
Nielsen, T.* et al. Type 2 diabetes risk allele near CENTD2 is associated with decreased glucose-stimulated insulin release. Diabetologia 54, 1052-1056 (2011)
Parra, E.J.* et al. Genome-wide association study of type 2 diabetes in a sample from Mexico City and a meta-analysis of a Mexican-American sample from Starr County, Texas. Diabetologia 54, 2038-2046 (2011)
Simonen-Tikka, M.-L.* et al. Human enterovirus infections in children at increased risk for type 1 diabetes: The Babydiet study. Diabetologia 54, 2995-3002 (2011)
Ziegler, A.-G.* ; Mollenhauer, U. ; Achenbach, P. & Bonifacio, E.* Anti-CCL3 autoantibodies are not markers of type 1 diabetes when measured by a commercial ELISA method. Diabetologia 54, 699-700 (2011)
Achenbach, P. et al. Autoantibodies to zinc transporter 8 and SLC30A8 genotype stratify type 1 diabetes risk. Diabetologia 52, 1881-1888 (2009)
Icks, A.* et al. Differences in trends in estimated incidence of myocardial infarction in non-diabetic and diabetic people: Monitoring Trends and Determinants on Cardiovascular Diseases (MONICA)/Cooperative Health Research in the Region of Augsburg (KORA) registry. Diabetologia 52, 1836-1841 (2009)
Herder, C.* et al. Effect of macrophage migration inhibitory factor (MIF) gene variants and MIF serum concentrations on the risk of type 2 diabetes: Results from the MONICA/KORA Augsburg Case-Cohort Study, 1984-2002. Diabetologia 51, 276-284 (2008)
Hoffmann, K.* et al. A German genome-wide linkage scan for type 2 diabetes supports the existence of a metabolic syndrome locus on chromosome 1p36.13 and a type 2 diabetes locus on chromosome 16p12.2. Diabetologia 50, 418-1422 (2007)
Thorand, B. ; Baumert, J.J. ; Herder, C.* ; Meisinger, C. & König, W.* Soluble thrombomodulin as a predictor of type 2 diabetes: Results from the MONICA/KORA Augsburg case-cohort study, 1984-1998. Diabetologia 50, 545-548 (2007)
Herder, C.* et al. Chemokines as risk factors for the type 2 diabetes: Results from the MONICA/KORA Augsburg study, 1984-2002. Diabetologia 49, 921-929 (2006)
Meisinger, C. ; Döring, A. ; Thorand, B. & Löwel, H. Association of cigarette smoking and tar and nicotine intake with development of type 2 diabetes mellitus in men and woman from the general population: The MONICA/KORA Augsburg Cohort study. Diabetologia 49, 1770-1776 (2006)
Meisinger, C. ; Löwel, H. ; Thorand, B. & Döring, A. Leisure time physical activity and the risk of type 2 diabetes in men and woman from the general population: The MONICA/KORA Augsburg Cohort Study. Diabetologia 48, 27-34 (2005)
Meisinger, C. ; Heier, M. & Löwel, H. Sleep disturbance as a predictor of type 2 diabetes mellitus in men and woman from the general population. Diabetologia 48, 235-241 (2005)
Rathmann, W.* et al. High prevalence of undiagnosed diabetes mellitus in Southern Germany: Target populations for efficient screening. The KORA survey 2000. Diabetologia 46, 182-189 (2003)
Müller, S.* et al. Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-alpha or its receptors. Diabetologia 45, 805-812 (2002)
Löwel, H. ; König, W.* ; Engel, S.* ; Hörmann, A. & Keil, U. The impact of diabetes mellitus on survival after myocardial infarction: can it be modified by drug treatment ? : Results of a population-based myocardial infarction register follow-up study. Diabetologia 43, 218-226 (2000)
Standl, E.* et al. Predictors of 10-year macrovascular and overall mortality in patients with NIDDM: The Munich General Practitioner Project. Diabetologia 39, 1540-1545 (1996)